Literature DB >> 25927274

Standardization of amniotic fluid leptin levels and utility in maternal overweight and fetal undergrowth.

M Scott-Finley1, J G Woo2, M Habli3, O Ramos-Gonzales4, J F Cnota4, Y Wang5, B D Kamath-Rayne6, A C Hinton1, W J Polzin7, T M Crombleholme8, R B Hinton4.   

Abstract

OBJECTIVE: Leptin is an adipokine that regulates energy homeostasis. The objective of this study was to establish a gestational age-specific standard for amniotic fluid leptin (AFL) levels and examine the relationship between AFL, maternal overweight and fetal growth restriction. STUDY
DESIGN: Amniotic fluid was obtained at mid-gestation from singleton gravidas, and leptin was quantified using enzyme-linked immunosorbent assay. Amniotic fluid samples from 321 term pregnancies were analyzed. Clinical data, including fetal ultrasound measurements and maternal and infant characteristics, were available for a subset of patients (n=45).
RESULTS: The median interquartile range AFL level was significantly higher at 14 weeks' gestation (2133 pg ml(-1) (1703 to 4347)) than after 33 weeks' gestation (519 pg ml(-1) (380 to 761), P trend<0.0001), an average difference of 102 pg ml(-1) per week. AFL levels were positively correlated with maternal pre-pregnancy body mass index (BMI) (r=0.36, P=0.03) adjusting for gestational age at measurement, but were not associated with fetal growth.
CONCLUSIONS: AFL levels are higher at mid-gestation than at late gestation, and are associated with maternal pre-pregnancy BMI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25927274     DOI: 10.1038/jp.2015.39

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  33 in total

Review 1.  The late effects of fetal growth patterns.

Authors:  F H Bloomfield; M H Oliver; J E Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-07       Impact factor: 5.747

Review 2.  Determinants of early life leptin levels and later life degenerative outcomes.

Authors:  Delia-Marina Alexe; Garyfallia Syridou; Eleni Th Petridou
Journal:  Clin Med Res       Date:  2006-12

3.  Codevelopment of genome-based therapeutics and companion diagnostics: insights from an Institute of Medicine roundtable.

Authors:  Robert T McCormack; Joanne Armstrong; Debra Leonard
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

4.  Use of routinely collected amniotic fluid for whole-genome expression analysis of polygenic disorders.

Authors:  Gyula Richárd Nagy; Balázs Gyõrffy; Orsolya Galamb; Béla Molnár; Bálint Nagy; Zoltán Papp
Journal:  Clin Chem       Date:  2006-09-28       Impact factor: 8.327

Review 5.  Biomarkers of maternal diabetes and its complication in pregnancy.

Authors:  Asher Ornoy
Journal:  Reprod Toxicol       Date:  2012-05-31       Impact factor: 3.143

Review 6.  Role of leptin in pregnancy: consequences of maternal obesity.

Authors:  D R Tessier; Z M Ferraro; A Gruslin
Journal:  Placenta       Date:  2013-01-16       Impact factor: 3.481

Review 7.  Placental growth factor (PlGF): a key to optimizing fetal growth.

Authors:  Nikolaos Vrachnis; Emmanouil Kalampokas; Stavros Sifakis; Nikolaos Vitoratos; Theodoros Kalampokas; Demetrios Botsis; Zoe Iliodromiti
Journal:  J Matern Fetal Neonatal Med       Date:  2013-02-14

8.  Gene expression patterns of vascular endothelial growth factor (VEGF-A) in human placenta from pregnancies with intrauterine growth restriction.

Authors:  Imre Szentpéteri; Attila Rab; László Kornya; Péter Kovács; József Gábor Joó
Journal:  J Matern Fetal Neonatal Med       Date:  2013-02-13

9.  Smoothing reference centile curves: the LMS method and penalized likelihood.

Authors:  T J Cole; P J Green
Journal:  Stat Med       Date:  1992-07       Impact factor: 2.373

10.  Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves.

Authors:  Alexandros Alexopoulos; Vasiliki Bravou; Stavros Peroukides; Loukas Kaklamanis; John Varakis; Dimitrios Alexopoulos; Helen Papadaki
Journal:  Int J Cardiol       Date:  2008-11-18       Impact factor: 4.164

View more
  3 in total

Review 1.  The Role of Leptin in Fetal Growth during Pre-Eclampsia.

Authors:  Victoria E de Knegt; Paula L Hedley; Jørgen K Kanters; Ida N Thagaard; Lone Krebs; Michael Christiansen; Ulrik Lausten-Thomsen
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 2.  Leptin action in normal and pathological pregnancies.

Authors:  Antonio Pérez-Pérez; Ayelén Toro; Teresa Vilariño-García; Julieta Maymó; Pilar Guadix; José L Dueñas; Manuel Fernández-Sánchez; Cecilia Varone; Víctor Sánchez-Margalet
Journal:  J Cell Mol Med       Date:  2017-11-21       Impact factor: 5.310

3.  Leptin Distribution in Rat Foetal and Extraembryonic Tissues in Late Gestation: A Physiological View of Amniotic Fluid Leptin.

Authors:  Zhi Xin Yau-Qiu; Catalina Picó; Ana María Rodríguez; Andreu Palou
Journal:  Nutrients       Date:  2020-08-21       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.